Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 23 Sept, 20:19 UTC

The Series A round was led by .406 Ventures, with support from Emerson Collective (managed by Yosemite), Forerunner, Serena Ventures and Japan-based MPower Partners. The post Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device appeared first on MedCity News.

businessscience

Sources

• T2Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening DeviceFierce Biotech / Fierce Healthcare / MedCity / GEN23 Sept, 20:19